Inventiva (IVA) Short term Debt (2018 - 2025)
Inventiva's (IVA) quarterly Short term Debt came in at $54.0 million in Q2 2025, up 17.94% year-on-year from $45.8 million in Q2 2024, and up 11.78% quarter-over-quarter from $48.3 million in Q4 2024.
Inventiva (IVA) Short term Debt (2018 - 2025) Analysis & Trends
Inventiva's Short term Debt history runs 8 years deep, the most recent figure standing at $54.0 million for Q2 2025.
- On a quarterly basis, Short term Debt rose 17.94% year-over-year to $54.0 million in Q2 2025; TTM through Jun 2025 was $54.0 million, a 17.94% increase from a year earlier, with the FY2024 full-year figure at $48.3 million, up 64.99% from the prior year.
- Short term Debt advanced to $54.0 million in Q2 2025 per IVA's latest filing, from $48.3 million in the prior quarter.
- Across five years, Short term Debt topped out at $54.0 million in Q2 2025 and bottomed at $1.5 million in Q4 2021.
- The 5-year median for Short term Debt is $30.8 million (2023), against an average of $34.3 million.
- Across the five-year window, Short term Debt jumped 6733.59% in 2021 and decreased 3.36% in 2023, its largest moves.
- Year by year, Short term Debt stood at $1.5 million in 2021, then surged by 1965.37% to $30.3 million in 2022, then retreated by 3.36% to $29.3 million in 2023, then soared by 64.99% to $48.3 million in 2024, then grew by 11.78% to $54.0 million in 2025.
- Per Business Quant, the three latest IVA Short term Debt figures stand at $54.0 million (Q2 2025), $48.3 million (Q4 2024), and $45.8 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 53.99 Mn |
| Dec 31, 2024 | 48.30 Mn |
| Jun 30, 2024 | 45.78 Mn |
| Dec 31, 2023 | 29.27 Mn |
| Jun 30, 2023 | 30.76 Mn |
| Dec 31, 2022 | 30.29 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Dec 31, 2020 | 21,461.22 |
| Dec 31, 2019 | 125,078.31 |
| Dec 31, 2018 | 172,350.86 |